Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma

Cancer Letters

Volumn 153, Issue 1-2, 2000, Pages 169-173

  Chen, Tse Ching ^a   Ng, Kwai Fong ^a   Lien, Jau Min ^a   Jeng, Long Bin ^a   Chen, Miin Fu ^a   Hsieh, Ling Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Hepatocellular carcinoma; Kip1; p27; Single strand conformation polymorphism

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEINS;

MARTES PENNANTI;

EID: 0034729507     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00366-9     Document Type: Article

References (26)

1. Department of Health, Health and Vital Statistics, Department of Health, Taiwan, 1998, pp. 10.
2. Anthony P.P. Tumours and tumour-like lesions of the liver and biliary tract. MacSween R.N.M., Anthony P.P., Scheuer P.J., Burt A.D., Portmann B.C. Pathology of the Liver, 3rd Edition. 1994;635-712 Churchill Livingstone, New York.
3. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
4. Hunter T., Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell. 79:1994;573-582.
5. DelSal G., Loda M., Pagano M. Cell cycle and cancer: critical events at the G1 restriction point. Crit. Rev. Oncogene. 7:1996;127-142.
6. Pardee A.B. G1 events and regulation of cell proliferation. Science. 246:1989;603-608.
7. Sherr C.J. G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
8. Peter M., Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell. 79:1994;181-184.
9. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
10. Kip1, a cyclin-Cdk inhibitor and a potential mediator of extracellular antimitogenic signals, Cell. 78:1994;59-66.
11. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21, Cell. 78:1994;67-74.
12. Kip1. A cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest, Genes Dev. 8:1994;9-22.
13. Ito Y., Matsuura N., Sakon M., Miyoshi E., Noda K., Takeda T., Umeshita K., Nagano H., Nakamori S., Dono K., Tsujimoto M., Nakahara M., Nakao K., Taniguchi N., Monden M. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology. (30):1999;90-99.
14. Kawamata N., Morosetti R., Miller C.W., Park D., Spirin K.S., Nakamaki T., Takeuchi S., Hatta Y., Simpson J., Wilczynski S., Lee Y.Y., Bartram C.R., Koeffler H.P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kipl in human malignancies. Cancer Res. 55:1995;2266-2269.
15. Takeuchi S., Koeffler H.P., Hinton D.R., Miyoshi I., Melmed S. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumor. J. Endocrinol. 157:1998;337-341.
16. Spirin K.S., Simpson J.F., Takeuchi S., Kawamata N., Miller C.W., Koeffler H.P. p27/Kip1 mutation found in breast cancer. Cancer Res. 56:1996;2400-2404.
17. Kawamata N., Morosetti R., Miller C.W., Park D., Spirin K.S., Nakamaki T., Takeuchi S. Hatta, J. Simpson, S. Wilczynski, Y.Y. Lee, C.R. Bartram, H.P Koeffler, Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies, Cancer Res. 55:1995;2266-2269.
18. Kip1 gene in non-Hodgkin's lymphoma and adult T-cell leukemia/lymphoma. Blood. 86:1995;1924-1930.
19. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutation of the p53 gene in hepatocellular carcinoma from Southern Africa. Nature. 350:1991;429-431.
20. Hsu I.C., Metcalf R.A., Sun T., Welsh J.A., Wang N.F., Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature. 350:1991;427-428.
21. Nishida N., Fukuda Y., Kokuryu H., Toguchida J., Yandell D.W., Ikenega M., Imura H., Ishizaki K. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res. 53:1993;368-372.
22. Oda T., Tsuda H., Scarpa A., Sakamoto M., Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52:1992;6358-6364.
23. INK4 in hepatocellular carcinoma. Hepatology. 24:1996;575-579.
24. WAF1/C1P1 expression and p53 mutation in hepatocellular carcinomas. Hepatology. 25:1997;575-579.
25. Kip1 expression in hepatocellular carcinomas. Cancer Lett. 132:1998;67-73.
26. INK4A gene in liver cancer. Int. J. Cancer. 67:1996;176-180.